-+ 0.00%
-+ 0.00%
-+ 0.00%

SEAPORT THERAPEUTICS - PLANS GLOBAL PHASE 2/3 GLYPHAGO TRIAL IN PATIENTS WITH GAD IN FIRST HALF OF 2027

Reuters·10/07/2026 11:00:00

Please log in to view news